Healthcare - Biotechnology - NASDAQ - US
$ 26.5
-9.99 %
$ 172 M
Market Cap
-1.44
P/E
BALANCE SHEET
326 M
ASSETS
99.8 M
LIABILITIES
226 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Instil Bio, Inc.
| Current Assets | 161 M |
| Cash & Short-Term Investments | 150 M |
| Receivables | 0 |
| Other Current Assets | 10.4 M |
| Non-Current Assets | 165 M |
| Long-Term Investments | 23.2 M |
| PP&E | 141 M |
| Other Non-Current Assets | 639 K |
| Current Liabilities | 10.6 M |
| Accounts Payable | 1.21 M |
| Short-Term Debt | 1.75 M |
| Other Current Liabilities | 7.6 M |
| Non-Current Liabilities | 89.2 M |
| Long-Term Debt | 84.3 M |
| Other Non-Current Liabilities | 4.94 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 10.7 | 43.7 | 37.6 | 241.7 | 8.9 |
| Short Term Investments | 141.2 | 217.2 | 416.5 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 3.2 | 0 |
| Inventory | 0 | 0 | 0 | 1.2 | 0 |
| Other Current Assets | 10.4 | 8.5 | 19.8 | 1.3 | 0.4 |
| Total Current Assets | 160.8 | 269.4 | 464.0 | 246.1 | 9.3 |
| PP&E | 141.1 | 209.3 | 122.0 | 55.3 | 0.2 |
| Intangible Assets | 0 | 0 | 10.1 | 10.1 | 0 |
| Goodwill | 0 | 0 | 5.7 | 5.7 | 0 |
| Long Term Investments | 23.2 | 0 | 0.5 | 50 K | 0 |
| Other Long Term Assets | 0.6 | 3.4 | 8.1 | 1.7 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 325.6 | 482.1 | 610.0 | 319.0 | 9.5 |
| LIABILITIES | |||||
| Accounts Payable | 1.2 | 2.4 | 5.6 | 3.5 | 1.0 |
| Short Term Debt | 1.8 | 2.4 | 0 | 0 | 0 |
| Other Current Liabilities | 7.6 | 28.0 | 35.3 | 9.2 | 0.4 |
| Total Current Liabilities | 10.6 | 32.8 | 41.4 | 13.3 | 1.4 |
| Long Term Debt | 84.3 | 77.5 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 2.4 | 2.5 | 0 |
| Other Liabilities | 4.9 | 8.2 | 11.0 | 342.9 | 14.9 |
| Total Liabilities | 99.8 | 118.5 | 54.8 | 358.6 | 16.4 |
| EQUITY | |||||
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (581.0) | (424.9) | (201.7) | (44.9) | (7.2) |
| Other Accumulative Comprehensive Income/Loss | (0.3) | (0.5) | 87 K | (0.3) | 0 |
| Total Equity | 225.8 | 363.6 | 555.2 | (39.6) | (6.9) |
| Total Liabilities and Equity | 325.6 | 482.1 | 610.0 | 319.0 | 9.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 6.5 | 6.5 | 6.5 | 6.4 | 6.4 |